Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to reshape Abbott’s diagnostics business by adding a broad cancer testing platform. Management is also rolling out changes in the Nutrition segment in response to ongoing operational challenges. For you as an investor, the Exact Sciences deal puts a spotlight on Abbott’s push deeper into cancer diagnostics, an area that continues to attract significant attention across healthcare. At the same time,…
Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset
Latest from Blog
Minnesota reaches $18.5 million settlement with nonprofit over child nutrition fraud claims
Partners in Nutrition will dissolve and turn over remaining funds under a consent judgment filed in Hennepin County Post Views: 3
Caitlin Clark turns cereal into a $100,000+ fundraiser: How the WNBA superstar used her platform to support youth programmes away from basketball
Caitlin Clark’s rise has translated off the court as the Indiana Fever star has made more of herself through commercial partnerships and community endeavors. One of the more unique examples has been
The Healthiest Vegetables to Add to Your Grocery List, According to Dietitians
Fresh or frozen, these veggies are a simple way to add fiber and essential vitamins to your diet. Post Views: 3
